← Open Payments lookup

AUSTIN COMBS: Open Payments

NPI 1215660683 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,356 in 70 payments from 22 companies in 2025. Trend: 2023 $32 · 2024 $614 · 2025 $1,356

Food & beverage: $1,356
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$234
Regeneron Healthcare Solutions, Inc.11$197
GENZYME CORPORATION12$187
GlaxoSmithKline, LLC.9$176
Lilly USA, LLC3$65
Takeda Pharmaceuticals U.S.A., Inc.3$55
Viatris Specialty LLC3$54
Boehringer Ingelheim Pharmaceuticals, Inc.2$43
Philips North America LLC2$43
Amgen Inc.2$38

Products named: DUPIXENT, NUCALA, FASENRA, TEZSPIRE, ZEPBOUND, GLASSIA, YUPELRI, TRELEGY ELLIPTA.

Industry payments across IN — which companies pay providers there.